Arrowhead Pharmaceuticals, Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Arrowhead Pharmaceuticals, Inc. filed 64 open-market sales worth $37.3 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Olukotun Adeoye Y, Director, sold 2,000 shares at $86.96 on 18 August 2026, filed 20 August 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 18 August 2026 | Olukotun Adeoye Y | Director | Sale | 2,000 | $86.96 | $173,920 | Form 4 |
| 18 August 2026 | Perry Michael S | Director | Sale | 11,600 | $87.30 | $1.0 million | Form 4 |
| 12 May 2026 | Lu Hongbo | Director | Sale | 2,970 | $76.88 | $228,334 | Form 4 |
| 23 April 2026 | Hamilton James C | Chief Medical Officer | Sale | 10,000 | $75.00 | $750,000 | Form 4 |
| 22 April 2026 | Apel Daniel Joseph | Chief Financial Officer | Sale | 3,208 | $70.11 | $224,913 | Form 4 |
| 22 April 2026 | Apel Daniel Joseph | Chief Financial Officer | Sale | 1,157 | $70.45 | $81,511 | Form 4 |
| 22 April 2026 | Apel Daniel Joseph | Chief Financial Officer | Sale | 8,730 | $71.92 | $627,862 | Form 4 |
| 5 March 2026 | Hamilton James C | Chief Medical Officer | Sale | 10,000 | $64.19 | $641,900 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 4,368 | $61.20 | $267,322 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 6,164 | $62.23 | $383,586 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 13,451 | $62.96 | $846,875 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 11,842 | $63.84 | $755,993 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 2,700 | $64.44 | $173,988 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 900 | $66.01 | $59,409 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 313 | $68.00 | $21,284 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 600 | $61.12 | $36,672 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 900 | $62.25 | $56,025 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 5,873 | $62.91 | $369,470 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 2,336 | $64.04 | $149,597 | Form 4 |
| 5 January 2026 | O'Brien Patrick | COO | Sale | 46 | $68.00 | $3,128 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 4,625 | $61.24 | $283,235 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 6,090 | $62.28 | $379,285 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 14,792 | $63.01 | $932,044 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 12,711 | $63.95 | $812,868 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 1,200 | $64.49 | $77,388 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 437 | $65.97 | $28,829 | Form 4 |
| 5 January 2026 | Hamilton James C | Chief Medical Officer | Sale | 309 | $68.00 | $21,012 | Form 4 |
| 2 January 2026 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 7,416 | $65.88 | $488,566 | Form 4 |
| 2 January 2026 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 5,771 | $66.39 | $383,137 | Form 4 |
| 29 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 35,181 | $69.33 | $2.4 million | Form 4 |
| 29 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 16,545 | $68.69 | $1.1 million | Form 4 |
| 26 December 2025 | Ferrari Mauro | Director | Sale | 7,530 | $70.00 | $527,100 | Form 4 |
| 22 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 10,012 | $68.33 | $684,120 | Form 4 |
| 22 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 2,574 | $68.85 | $177,220 | Form 4 |
| 19 December 2025 | Waddill William D. | Director | Sale | 2,416 | $66.66 | $161,051 | Form 4 |
| 19 December 2025 | Waddill William D. | Director | Sale | 5,451 | $68.01 | $370,723 | Form 4 |
| 19 December 2025 | Waddill William D. | Director | Sale | 500 | $68.53 | $34,265 | Form 4 |
| 19 December 2025 | Vakiener Victoria | Director | Sale | 2,799 | $66.63 | $186,497 | Form 4 |
| 19 December 2025 | Vakiener Victoria | Director | Sale | 5,281 | $67.97 | $358,950 | Form 4 |
| 19 December 2025 | Vakiener Victoria | Director | Sale | 1,960 | $68.39 | $134,044 | Form 4 |
| 19 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 3,979 | $66.67 | $265,280 | Form 4 |
| 19 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 8,147 | $68.01 | $554,077 | Form 4 |
| 19 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 1,319 | $68.48 | $90,325 | Form 4 |
| 19 December 2025 | Olukotun Adeoye Y | Director | Sale | 3,090 | $66.70 | $206,103 | Form 4 |
| 19 December 2025 | Olukotun Adeoye Y | Director | Sale | 6,083 | $68.04 | $413,887 | Form 4 |
| 19 December 2025 | Olukotun Adeoye Y | Director | Sale | 827 | $68.48 | $56,633 | Form 4 |
| 17 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 46,287 | $63.55 | $2.9 million | Form 4 |
| 17 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 35,750 | $64.51 | $2.3 million | Form 4 |
| 17 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 982 | $65.53 | $64,350 | Form 4 |
| 17 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 1,981 | $66.30 | $131,340 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 8,416 | $60.51 | $509,252 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 10,963 | $61.25 | $671,484 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 14,095 | $62.12 | $875,581 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 8,476 | $62.94 | $533,479 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 6,661 | $64.29 | $428,236 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 1,000 | $64.96 | $64,960 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 1,300 | $65.77 | $85,501 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 166 | $66.77 | $11,084 | Form 4 |
| 16 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 3,221 | $67.87 | $218,609 | Form 4 |
| 15 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 100,532 | $68.67 | $6.9 million | Form 4 |
| 15 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 21,321 | $69.28 | $1.5 million | Form 4 |
| 15 December 2025 | Anzalone Christopher Richard | Chief Executive Officer | Sale | 8,147 | $69.96 | $569,964 | Form 4 |
| 5 December 2025 | Perry Michael S | Director | Sale | 16,250 | $61.03 | $991,738 | Form 4 |
| 28 November 2025 | Ferrari Mauro | Director | Sale | 8,750 | $56.39 | $493,412 | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Arrowhead Pharmaceuticals, Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.